Bumetanide Equivalent to 80 mg Furosemide
2 mg of bumetanide (Bumex) is equivalent to 80 mg of furosemide (Lasix). 1, 2
Established Equivalence Ratio
- The standard conversion ratio is 1:40, meaning 1 mg of bumetanide equals 40 mg of furosemide. 1, 2
- Therefore, 80 mg of furosemide requires 2 mg of bumetanide (80 ÷ 40 = 2). 1
- This 1:40 potency ratio is consistently supported across FDA labeling, clinical guidelines, and pharmacological research. 1, 2, 3
Route-Specific Considerations
- For IV administration: 2 mg bumetanide IV equals 80 mg furosemide IV using the same 1:40 ratio. 1, 2
- For oral administration: The conversion remains 2 mg bumetanide PO equals 80 mg furosemide PO, though bumetanide has superior bioavailability (80% vs 40% for furosemide). 4, 5
- When converting from IV to oral routes, bumetanide's higher bioavailability means the oral dose can remain the same as the IV dose, whereas furosemide often requires dose increases. 4
Critical Pharmacokinetic Differences
- Duration of action: Bumetanide has a significantly shorter duration (4-6 hours) compared to furosemide (6-8 hours), often necessitating twice-daily dosing rather than once-daily. 1
- Onset of action: Both drugs produce diuresis within minutes IV and peak at 30-75 minutes orally, with virtually superimposable time-response curves. 6, 4
- Bioavailability advantage: Bumetanide's 80% oral bioavailability versus furosemide's 40% makes oral bumetanide more reliable, particularly in heart failure patients with gut edema. 4, 5
Practical Dosing Algorithm for Conversion
Step 1: Calculate equivalent dose using 1:40 ratio
Step 2: Adjust dosing frequency
- If patient was on furosemide 80 mg once daily, consider bumetanide 1 mg twice daily (morning and early afternoon) due to shorter duration. 1
- Alternatively, start with 2 mg once daily and monitor response over 24 hours. 1
Step 3: Monitor response within 24-48 hours
- Check daily weights targeting 0.5-1.0 kg loss per day. 1
- Assess urine output and clinical signs of congestion. 1
- Verify electrolytes (sodium, potassium) and renal function within 1-2 weeks. 1
Important Clinical Caveats
- Maximum daily dose: Bumetanide should not exceed 10 mg/day. 1
- Electrolyte monitoring: For every 200 mEq sodium excreted, bumetanide causes approximately 35 mEq potassium loss versus 50 mEq with furosemide, though this difference is not clinically significant. 6
- Diuretic resistance: If adequate diuresis is not achieved with bumetanide 2 mg twice daily (equivalent to furosemide 160 mg/day), add a thiazide diuretic or aldosterone antagonist rather than exceeding maximum loop diuretic doses. 1
- Heart failure patients: Delayed absorption in CHF reduces peak drug concentrations for both agents, potentially requiring higher doses or IV administration. 5
- Ototoxicity risk: Bumetanide may have a lower incidence of ototoxicity compared to furosemide, making it preferable in high-risk patients. 3, 7
Common Pitfalls to Avoid
- Underdosing due to short duration: Do not assume once-daily bumetanide 2 mg will provide 24-hour coverage equivalent to furosemide 80 mg once daily; consider split dosing. 1
- Ignoring bioavailability advantage: In patients with gut edema or malabsorption, bumetanide's superior oral bioavailability makes it more reliable than furosemide. 4, 5
- Combining with NSAIDs: Avoid concurrent NSAID use, which blocks diuretic effects and worsens renal function. 1
- Excessive sodium intake: High dietary sodium (>2-3 g/day) can create apparent diuretic resistance; counsel patients on sodium restriction. 1